New Ebola Vaccine for Bundibugyo Strain Enters Human Clinical Trials

A new vaccine targeting the Bundibugyo strain of the Ebola virus, which has been devastating the Democratic Republic of the Congo, has begun human clinical trials.

24 Jul, 19:21 — 24 Jul, 19:21

Post Share

Sources

Showing 1 of 1 sources

forbes14d ago

New Ebola Vaccine Enters Human Clinical Trials

The Bundibugyo strain of the Ebola virus has been devastating the Democratic Republic of the Congo, with no vaccine currently approved to protect against the strain.

By Victoria Forster, Contributor

Read full article →

PERSPECTA

PERSPECTA

New Ebola Vaccine for Bundibugyo Strain Enters Human Clinical Trials

Sources

New Ebola Vaccine Enters Human Clinical Trials

Related Stories

Experts Urge Early Preparation for Hotter Summers, Beyond Air Conditioning

Excessive Protein Intake Poses Risks to Kidneys and Increases Cancer Risk

Human Lifespan Could Reach 200 Years, Limited by Cell Damage

Medicare Patient Faces Double Deductible Payment After Short Hospital Stay

PERSPECTA